{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:17:26Z","timestamp":1768263446981,"version":"3.49.0"},"reference-count":76,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1097\/cpm.0000000000000322","type":"journal-article","created":{"date-parts":[[2019,8,15]],"date-time":"2019-08-15T14:53:47Z","timestamp":1565880827000},"page":"118-125","source":"Crossref","is-referenced-by-count":9,"title":["Biomarkers in Pulmonary Infections"],"prefix":"10.1097","volume":"26","author":[{"given":"Pedro","family":"P\u00f3voa","sequence":"first","affiliation":[]},{"given":"Lu\u00eds","family":"Coelho","sequence":"additional","affiliation":[]},{"given":"Lieuwe J.","family":"Bos","sequence":"additional","affiliation":[]}],"member":"276","reference":[{"key":"R1-20210124","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0140-6736(17)32152-9","article-title":"Global, regional, and national age-sex specific mortality for 264 causes of death, 1980\u20132016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"390","year":"2017","journal-title":"Lancet"},{"key":"R2-20210124","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1183\/09031936.00216711","article-title":"Hospital admissions of adults with community-acquired pneumonia in Portugal between 2000 and 2009","volume":"41","author":"Froes","year":"2013","journal-title":"Eur Respir J"},{"key":"R3-20210124","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S2213-2600(15)00326-4","article-title":"Incidence and prognosis of ventilator-associated tracheobronchitis (TAVeM): a multicentre, prospective, observational study","volume":"3","author":"Martin-Loeches","year":"2015","journal-title":"Lancet Respir Med"},{"key":"R4-20210124","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21037\/arh.2017.12.03","article-title":"Epidemiology, pathophysiology, and microbiology of communityacquired pneumonia","volume":"2","author":"Cill\u00f3niz","year":"2018","journal-title":"Ann Res Hosp"},{"key":"R5-20210124","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1136\/thoraxjnl-2013-204282","article-title":"Risk factors for community-acquired pneumonia in adults in Europe: a literature review","volume":"68","author":"Torres","year":"2013","journal-title":"Thorax"},{"key":"R6-20210124","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1056\/NEJMoa1500245","article-title":"Community-acquired pneumonia requiring hospitalization among U.S. adults","volume":"373","author":"Jain","year":"2015","journal-title":"N Engl J Med"},{"key":"R7-20210124","doi-asserted-by":"crossref","first-page":"269","DOI":"10.7883\/yoken.67.269","article-title":"High incidence of community-acquired pneumonia among rapidly aging population in Japan: a prospective hospital-based surveillance","volume":"67","author":"Takaki","year":"2014","journal-title":"Jpn J Infect Dis"},{"key":"R8-20210124","doi-asserted-by":"crossref","first-page":"pii:1700582","DOI":"10.1183\/13993003.00582-2017","article-title":"International ERS\/ESICM\/ESCMID\/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: Guidelines for the management of hospital-acquired pneumonia (HAP)\/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociacion Latinoamericana del Torax (ALAT)","volume":"50","author":"Torres","year":"2017","journal-title":"Eur Respir J"},{"key":"R9-20210124","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ajic.2017.08.036","article-title":"Hospital acquired pneumonia prevention initiative-2: incidence of nonventilator hospital-acquired pneumonia in the United States","volume":"46","author":"Baker","year":"2018","journal-title":"Am J Infect Control"},{"key":"R10-20210124","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ajic.2017.09.005","article-title":"The epidemiology of nonventilator hospital-acquired pneumonia in the United States","volume":"46","author":"Giuliano","year":"2018","journal-title":"Am J Infect Control"},{"key":"R11-20210124","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ajic.2011.05.020","article-title":"International Nosocomial Infection Control Consortium (INICC) report, data summary of 36 countries, for 2004\u20132009","volume":"40","author":"Rosenthal","year":"2012","journal-title":"Am J Infect Control"},{"key":"R12-20210124","doi-asserted-by":"crossref","first-page":"95.e2","DOI":"10.1016\/j.ajic.2009.12.004","article-title":"International Nosocomial Infection Control Consortium (INICC) report, data summary for 2003\u20132008, issued June 2009","volume":"38","author":"Rosenthal","year":"2010","journal-title":"Am J Infect Control"},{"issue":"suppl 2","key":"R13-20210124","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1086\/511159","article-title":"Infectious Diseases Society of America\/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults","volume":"44","author":"Mandell","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R14-20210124","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1164\/rccm.201501-0017OC","article-title":"Early chest computed tomography scan to assist diagnosis and guide treatment decision for suspected community-acquired pneumonia","volume":"192","author":"Claessens","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"R15-20210124","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ajem.2012.08.041","article-title":"High discordance of chest x-ray and computed tomography for detection of pulmonary opacities in ED patients: implications for diagnosing pneumonia","volume":"31","author":"Self","year":"2013","journal-title":"Am J Emerg Med"},{"key":"R16-20210124","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s00134-016-4239-1","article-title":"Does this patient have VAP?","volume":"42","author":"Chastre","year":"2016","journal-title":"Intensive Care Med"},{"key":"R17-20210124","doi-asserted-by":"crossref","first-page":"425","DOI":"10.7326\/M15-1840","article-title":"Appropriate antibiotic use for acute respiratory tract infection in adults: advice for high-value care from the American College of Physicians and the Centers for Disease Control and Prevention","volume":"164","author":"Harris","year":"2016","journal-title":"Ann Intern Med"},{"key":"R18-20210124","doi-asserted-by":"crossref","first-page":"208","DOI":"10.21037\/atm.2017.04.04","article-title":"Biomarker-guided antibiotic therapy-strengths and limitations","volume":"5","author":"Nora","year":"2017","journal-title":"Ann Transl Med"},{"key":"R19-20210124","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/QCO.0b013e3282f47c32","article-title":"Serum markers in community-acquired pneumonia and ventilator-associated pneumonia","volume":"21","author":"P\u00f3voa","year":"2008","journal-title":"Curr Opin Infect Dis"},{"key":"R20-20210124","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1097\/01.CCM.0000065186.67848.3A","article-title":"Measures, markers, and mediators: toward a staging system for clinical sepsis. A report of the Fifth Toronto Sepsis Roundtable, Toronto, Ontario, Canada, October 25\u201326, 2000","volume":"31","author":"Marshall","year":"2003","journal-title":"Crit Care Med"},{"key":"R21-20210124","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/2110-5820-2-32","article-title":"Biomarker-guided antibiotic therapy in adult critically ill patients: a critical review","volume":"2","author":"P\u00f3voa","year":"2012","journal-title":"Ann Intensive Care"},{"key":"R22-20210124","doi-asserted-by":"crossref","first-page":"R76","DOI":"10.1186\/cc6922","article-title":"The role of corticosteroids in severe community-acquired pneumonia: a systematic review","volume":"12","author":"Salluh","year":"2008","journal-title":"Crit Care"},{"key":"R23-20210124","doi-asserted-by":"crossref","first-page":"R129","DOI":"10.1186\/cc10242","article-title":"C-reactive protein in critically ill cancer patients with sepsis: influence of neutropenia","volume":"15","author":"P\u00f3voa","year":"2011","journal-title":"Crit Care"},{"key":"R24-20210124","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00134-003-1664-8","article-title":"Procalcitonin and C-reactive protein plasma concentrations in nonseptic uremic patients undergoing hemodialysis","volume":"29","author":"Dahaba","year":"2003","journal-title":"Intensive Care Med"},{"key":"R25-20210124","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3947\/ic.2014.46.1.1","article-title":"Biomarkers of sepsis","volume":"46","author":"Cho","year":"2014","journal-title":"Infect Chemother"},{"key":"R26-20210124","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/s001340000624","article-title":"Procalcitonin as a marker of the systemic inflammatory response to infection","volume":"26","author":"Reinhart","year":"2000","journal-title":"Intensive Care Med"},{"key":"R27-20210124","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1177\/0310057X0203000302","article-title":"Procalcitonin and proinflammatory cytokine clearance during continuous venovenous haemofiltration in septic patients","volume":"30","author":"Dahaba","year":"2002","journal-title":"Anaesth Intensive Care"},{"key":"R28-20210124","doi-asserted-by":"crossref","first-page":"R63","DOI":"10.1186\/cc4892","article-title":"Early identification of intensive care unit-acquired infections with daily monitoring of C-reactive protein: a prospective observational study","volume":"10","author":"P\u00f3voa","year":"2006","journal-title":"Crit Care"},{"key":"R29-20210124","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1007\/s00134-008-1112-x","article-title":"Usefulness of procalcitonin for the diagnosis of ventilator-associated pneumonia","volume":"34","author":"Luyt","year":"2008","journal-title":"Intensive Care Med"},{"key":"R30-20210124","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13613-016-0134-8","article-title":"Biomarker kinetics in the prediction of VAP diagnosis: results from the BioVAP study","volume":"6","author":"P\u00f3voa","year":"2016","journal-title":"Ann Intensive Care"},{"key":"R31-20210124","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1378\/chest.125.4.1335","article-title":"Contribution of C-reactive protein to the diagnosis and assessment of severity of community-acquired pneumonia","volume":"125","author":"Almirall","year":"2004","journal-title":"Chest"},{"key":"R32-20210124","first-page":"547","article-title":"Aetiology and prediction of pneumonia in lower respiratory tract infection in primary care","volume":"57","author":"Holm","year":"2007","journal-title":"Br J Gen Pract"},{"key":"R33-20210124","first-page":"434","article-title":"Diagnostic value of signs, symptoms and laboratory values in lower respiratory tract infection","volume":"136","author":"Stolz","year":"2006","journal-title":"Swiss Med Wkly"},{"key":"R34-20210124","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1164\/rccm.200512-1922OC","article-title":"Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial","volume":"174","author":"Christ-Crain","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"R35-20210124","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/S0140-6736(04)15591-8","article-title":"Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial","volume":"363","author":"Christ-Crain","year":"2004","journal-title":"Lancet"},{"key":"R36-20210124","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/jama.2009.1297","article-title":"Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial","volume":"302","author":"Schuetz","year":"2009","journal-title":"JAMA"},{"key":"R37-20210124","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jinf.2013.03.003","article-title":"Can an etiologic agent be identified in adults who are hospitalized for community-acquired pneumonia: results of a one-year study","volume":"67","author":"Musher","year":"2013","journal-title":"J Infect"},{"key":"R38-20210124","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/infdis\/jit579","article-title":"Serum procalcitonin level, viral polymerase chain reaction analysis, and lower respiratory tract infection","volume":"209","author":"Musher","year":"2014","journal-title":"J Infect Dis"},{"key":"R39-20210124","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1465-9921-10-65","article-title":"Inflammatory parameters predict etiologic patterns but do not allow for individual prediction of etiology in patients with CAP: results from the German competence network CAPNETZ","volume":"10","author":"Kruger","year":"2009","journal-title":"Respir Res"},{"key":"R40-20210124","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/cid\/cix317","article-title":"Procalcitonin as a marker of etiology in adults hospitalized with community-acquired pneumonia","volume":"65","author":"Self","year":"2017","journal-title":"Clin Infect Dis"},{"key":"R41-20210124","article-title":"Procalcitonin to distinguish viral from bacterial pneumonia: a systematic review and meta-analysis","author":"Kamat","year":"2019","journal-title":"Clin Infect Dis"},{"key":"R42-20210124","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s00134-018-5141-9","article-title":"Procalcitonin algorithm to guide initial antibiotic therapy in acute exacerbations of COPD admitted to the ICU: a randomized multicenter study","volume":"44","author":"Daubin","year":"2018","journal-title":"Intensive Care Med"},{"key":"R43-20210124","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1056\/NEJMoa1802670","article-title":"Procalcitonin-guided use of antibiotics for lower respiratory tract infection","volume":"379","author":"Huang","year":"2018","journal-title":"N Engl J Med"},{"key":"R44-20210124","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1164\/rccm.201709-1908OC","article-title":"Initial inflammatory profile in community-acquired pneumonia depends on time since onset of symptoms","volume":"198","author":"Mendez","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"R45-20210124","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1007\/s00134-004-2434-y","article-title":"C-reactive protein used as an early indicator of infection in patients with systemic inflammatory response syndrome","volume":"30","author":"Sierra","year":"2004","journal-title":"Intensive Care Med"},{"key":"R46-20210124","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1469-0691.2004.01044.x","article-title":"C-reactive protein as a marker of infection in critically ill patients","volume":"11","author":"P\u00f3voa","year":"2005","journal-title":"Clin Microbiol Infect"},{"key":"R47-20210124","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jcrc.2018.09.036","article-title":"C-reactive protein and procalcitonin profile in ventilator-associated lower respiratory infections","volume":"48","author":"Coelho","year":"2018","journal-title":"J Crit Care"},{"key":"R48-20210124","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1183\/09031936.05.00071704","article-title":"C-reactive protein as a marker of ventilator-associated pneumonia resolution: a pilot study","volume":"25","author":"P\u00f3voa","year":"2005","journal-title":"Eur Respir J"},{"key":"R49-20210124","doi-asserted-by":"crossref","first-page":"R92","DOI":"10.1186\/cc6105","article-title":"Usefulness of C-reactive protein in monitoring the severe community-acquired pneumonia clinical course","volume":"11","author":"Coelho","year":"2007","journal-title":"Crit Care"},{"key":"R50-20210124","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jinf.2010.06.005","article-title":"C-reactive protein: a tool in the follow-up of nosocomial pneumonia","volume":"61","author":"Moreno","year":"2010","journal-title":"J Infect"},{"key":"R51-20210124","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jcrc.2017.07.021","article-title":"Patterns of C-reactive protein ratio predicts outcomes in healthcare-associated pneumonia in critically ill patients with cancer","volume":"42","author":"Rabello","year":"2017","journal-title":"J Crit Care"},{"key":"R52-20210124","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jcrc.2017.05.007","article-title":"Biomarkers kinetics in the assessment of ventilator-associated pneumonia response to antibiotics\u2014results from the BioVAP study","volume":"41","author":"P\u00f3voa","year":"2017","journal-title":"J Crit Care"},{"key":"R53-20210124","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1186\/cc11291","article-title":"Patterns of c-reactive protein RATIO response in severe community-acquired pneumonia: a cohort study","volume":"16","author":"Coelho","year":"2012","journal-title":"Crit Care"},{"key":"R54-20210124","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1164\/rccm.200406-746OC","article-title":"Procalcitonin kinetics as a prognostic marker of ventilator-associated pneumonia","volume":"171","author":"Luyt","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"R55-20210124","first-page":"19","article-title":"C-reactive protein concentration as a predictor of in-hospital mortality after ICU discharge: a nested case-control study","volume":"9","author":"Litton","year":"2007","journal-title":"Crit Care Resusc"},{"key":"R56-20210124","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00134-007-0928-0","article-title":"C-reactive protein concentration as a predictor of in-hospital mortality after ICU discharge: a prospective cohort study","volume":"34","author":"Ho","year":"2008","journal-title":"Intensive Care Med"},{"key":"R57-20210124","doi-asserted-by":"crossref","first-page":"525.e9","DOI":"10.1016\/j.jcrc.2011.10.013","article-title":"Failure to reduce C-reactive protein levels more than 25% in the last 24 hours before intensive care unit discharge predicts higher in-hospital mortality: a cohort study","volume":"27","author":"Ranzani","year":"2012","journal-title":"J Crit Care"},{"key":"R58-20210124","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3109\/1354750X.2012.654407","article-title":"Assessment of risk factors for in-hospital mortality after intensive care unit discharge","volume":"17","author":"Araujo","year":"2012","journal-title":"Biomarkers"},{"key":"R59-20210124","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jcrc.2016.02.006","article-title":"Procalcitonin concentrations as a predictor of unexpected readmission and mortality after intensive care unit discharge: A retrospective cohort study","volume":"33","author":"Zhou","year":"2016","journal-title":"J Crit Care"},{"key":"R60-20210124","doi-asserted-by":"crossref","first-page":"e114007","DOI":"10.1371\/journal.pone.0114007","article-title":"Serum procalcitonin level and SOFA score at discharge from the intensive care unit predict post-intensive care unit mortality: a prospective study","volume":"9","author":"Matsumura","year":"2014","journal-title":"PLoS One"},{"key":"R61-20210124","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1183\/09031936.00053209","article-title":"Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study","volume":"34","author":"Stolz","year":"2009","journal-title":"Eur Respir J"},{"key":"R62-20210124","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0140-6736(09)61879-1","article-title":"Use of procalcitonin to reduce patients\u2019 exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial","volume":"375","author":"Bouadma","year":"2010","journal-title":"Lancet"},{"key":"R63-20210124","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1097\/CCM.0b013e31821e8791","article-title":"Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial","volume":"39","author":"Jensen","year":"2011","journal-title":"Crit Care Med"},{"key":"R64-20210124","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S1473-3099(16)00053-0","article-title":"Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial","volume":"16","author":"de Jong","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"R65-20210124","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1097\/CCM.0b013e31828e969f","article-title":"Procalcitonin versus C-reactive protein for guiding antibiotic therapy in sepsis: a randomized trial","volume":"41","author":"Oliveira","year":"2013","journal-title":"Crit Care Med"},{"key":"R66-20210124","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.chest.2018.12.029","article-title":"Procalcitonin-guided antibiotic discontinuation and mortality in critically ill adults: a systematic review and meta-analysis","volume":"155","author":"Pepper","year":"2019","journal-title":"Chest"},{"key":"R67-20210124","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1093\/cid\/ciw353","article-title":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society","volume":"63","author":"Kalil","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"suppl 6","key":"R68-20210124","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1111\/j.1469-0691.2011.03672.x","article-title":"Guidelines for the management of adult lower respiratory tract infections\u2014full version","volume":"17","author":"Woodhead","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"R69-20210124","doi-asserted-by":"crossref","first-page":"e58782","DOI":"10.1371\/journal.pone.0058782","article-title":"Proteomic profiling of bronchoalveolar lavage fluid in critically ill patients with ventilator-associated pneumonia","volume":"8","author":"Nguyen","year":"2013","journal-title":"PLoS ONE"},{"key":"R70-20210124","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ebiom.2017.03.034","article-title":"Metabolic profiling in patients with pneumonia on intensive care","volume":"18","author":"Antcliffe","year":"2017","journal-title":"EBioMedicine"},{"key":"R71-20210124","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.molmed.2015.08.001","article-title":"Exhaled molecular fingerprinting in diagnosis and monitoring: validating volatile promises","volume":"21","author":"Boots","year":"2015","journal-title":"Trends Mol Med"},{"key":"R72-20210124","doi-asserted-by":"crossref","first-page":"L751","DOI":"10.1152\/ajplung.00449.2018","article-title":"Exhaled breath metabolomics reveals a pathogen-specific response in a rat pneumonia model for two human pathogenic bacteria: a proof-of-concept study","volume":"316","author":"van Oort","year":"2019","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"R73-20210124","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1152\/japplphysiol.00099.2013","article-title":"Secondary electrospray ionization-mass spectrometry (SESI-MS) breathprinting of multiple bacterial lung pathogens, a mouse model study","volume":"114","author":"Zhu","year":"2013","journal-title":"J Appl Physiol"},{"key":"R74-20210124","doi-asserted-by":"crossref","first-page":"024001","DOI":"10.1088\/1752-7163\/aaa499","article-title":"The potential role of exhaled breath analysis in the diagnostic process of pneumonia\u2014a systematic review","volume":"12","author":"van Oort","year":"2018","journal-title":"J Breath Res"},{"key":"R75-20210124","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12890-016-0353-7","article-title":"BreathDx\u2014molecular analysis of exhaled breath as a diagnostic test for ventilator-associated pneumonia: protocol for a European multicentre observational study","volume":"17","author":"van Oort","year":"2017","journal-title":"BMC Pulm Med"},{"key":"R76-20210124","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1136\/thoraxjnl-2016-209158","article-title":"The dynamics of the pulmonary microbiome during mechanical ventilation in the intensive care unit and the association with occurrence of pneumonia","volume":"72","author":"Zakharkina","year":"2017","journal-title":"Thorax"}],"container-title":["Clinical Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00045413-201907000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,24]],"date-time":"2021-01-24T06:35:13Z","timestamp":1611470113000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00045413-201907000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":76,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/cpm.0000000000000322","relation":{},"ISSN":["1068-0640"],"issn-type":[{"value":"1068-0640","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]}}}